Filing Details

Accession Number:
0001209191-15-049837
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-03 19:05:03
Reporting Period:
2015-06-01
Filing Date:
2015-06-03
Accepted Time:
2015-06-03 19:05:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1374690 Zafgen Inc. ZFGN Pharmaceutical Preparations (2834) 203857670
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1611061 Y. Avi Goldberg C/O Zafgen, Inc.
175 Portland Street, 4Th Floor
Boston MA 02114
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-06-01 2,000 $32.23 61,734 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This sale of 2,000 shares of Common Stock by the Reporting Person was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. At the time of the Reporting Person's last ownership report, the Reporting Person was a partner at Greatpoint Ventures Fund I, LLC ("GPV") and reported as beneficial owned 345,642 shares of Common Stock owned by GPV. On December 29, 2014, GPV made a distribution of 115,880 shares of Common Stock to the Reporting Person upon the termination of the relationship between the Reporting Person and GPV. The reporting person no longer reports as beneficially owned any securities owned by GPV. On April 17, 2015, the Reporting Person transferred 52,146 shares pursuant to a court decree. The Reporting Person no longer reports as beneficially owned these transferred shares.